Role of daratumumab in the frontline management of multiple myeloma: a narrative review
S Yadav, S Gundeti, A Bhave, U Deb… - Expert Review of …, 2023 - Taylor & Francis
Introduction The prevalence of multiple myeloma (MM) has gradually increased over the last
few decades in India due to growing population, better disease awareness, and improved …
few decades in India due to growing population, better disease awareness, and improved …
[HTML][HTML] Global, regional, and national burden and quality of care of multiple myeloma, 1990–2019
J Geng, J Zhao, R Fan, Z Zhu, Y Zhang… - Journal of Global …, 2024 - ncbi.nlm.nih.gov
Background Multiple myeloma (MM) is the second most common haematologic malignancy,
presenting a great disease burden on the general population; however, the quality of care of …
presenting a great disease burden on the general population; however, the quality of care of …
[PDF][PDF] Predictive Role of IGFBP-7 and Activin A in Newly Diagnosis of Multiple Myeloma
ZT Habeeb, ZAR Al-Sharifi, RM Rahem - History of Medicine, 2023 - historymedjournal.com
Plasma cells tumor or multiple myeloma (MM) is a hematological malignancy and
determined the second most common cancer characterized by extensive renal deficiency …
determined the second most common cancer characterized by extensive renal deficiency …
[引用][C] Predictive Biomarkers of Newly Diagnosed Patients with Plasma Cells Tumor
ZT Habeeb, ZAR Al-Sharifi, RM Rahem - History of Medicine, 2023